Free Trial
NASDAQ:VRPX

Virpax Pharmaceuticals (VRPX) Stock Price, News & Analysis

Virpax Pharmaceuticals logo
$0.02 +0.01 (+90.91%)
As of 10:18 AM Eastern

About Virpax Pharmaceuticals Stock (NASDAQ:VRPX)

Advanced

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.01
$0.04
52-Week Range
$0.01
$26.25
Volume
2,390 shs
Average Volume
149,280 shs
Market Capitalization
$26.08 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Virpax Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
1st Percentile Overall Score

VRPX MarketRank™: 

Virpax Pharmaceuticals scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Virpax Pharmaceuticals.

  • Price to Book Value per Share Ratio

    Virpax Pharmaceuticals has a P/B Ratio of 0.01. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.96% of the outstanding shares of Virpax Pharmaceuticals have been sold short.
  • Short Interest Ratio / Days to Cover

    Virpax Pharmaceuticals has a short interest ratio ("days to cover") of 6.6.
  • Change versus previous month

  • Dividend Yield

    Virpax Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Virpax Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.96% of the outstanding shares of Virpax Pharmaceuticals have been sold short.
  • Short Interest Ratio / Days to Cover

    Virpax Pharmaceuticals has a short interest ratio ("days to cover") of 6.6.
  • Change versus previous month

  • MarketBeat Follows

    Only 1 people have added Virpax Pharmaceuticals to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Virpax Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.70% of the stock of Virpax Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    Only 32.23% of the stock of Virpax Pharmaceuticals is held by institutions.

  • Read more about Virpax Pharmaceuticals' insider trading history.
Receive VRPX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VRPX Stock News Headlines

Virpax Pharmaceuticals Inc trading halted, news pending
Shots officially fired…
Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the rights to deliver direct-to-cell service nationwide — a move tech analyst Jeff Brown says could shape the backbone of the coming space economy and create fortunes on a scale not seen since the rise of NVIDIA.tc pixel
Virpax receives positive Probudur results for dose range study
Virpax Pharmaceuticals announces 1-for-25 reverse stock split
See More Headlines

VRPX Stock Analysis - Frequently Asked Questions

Virpax Pharmaceuticals' stock was trading at $9.4975 on January 1st, 2025. Since then, VRPX shares have decreased by 99.8% and is now trading at $0.0210.

Shares of Virpax Pharmaceuticals reverse split on Friday, March 1st 2024.The 1-10 reverse split was announced on Friday, March 1st 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, March 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Virpax Pharmaceuticals (VRPX) raised $15 million in an initial public offering on Wednesday, February 17th 2021. The company issued 1,400,000 shares at $10.00-$12.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO.

Shares of VRPX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Virpax Pharmaceuticals investors own include AMC Entertainment (AMC), Dare Bioscience (DARE), Rallybio (RLYB), Plug Power (PLUG), SNDL (SNDL) and SOS (SOS).

Company Calendar

Today
10/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VRPX
CIK
1708331
Fax
N/A
Employees
7
Year Founded
2017

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.19 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-1,554.34%
Return on Assets
-338.29%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.13
Quick Ratio
0.13

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.65 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
1,242,000
Free Float
4,707,000
Market Cap
$26.08 thousand
Optionable
Not Optionable
Beta
1.96

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:VRPX) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners